-+ 0.00%
-+ 0.00%
-+ 0.00%

Samsung Bioepis signed a biosimilar agreement of up to US$420 million with Teva.

Zhitongcaijing·11/03/2026 08:01:11
Listen to the news
Samsung Bioepis signed a biosimilar agreement of up to US$420 million with Teva.